Prefer a gentler titration
The broader question of whether stacking an amylin analogue onto a GLP-1 drug earns its place is exactly what the REDEFINE program was built to answer, and it is discussed further in whether research validates cagrilintides role in appetite regulation
"One thing that we've noticed and has been brought to our attention is that specifically, GLP weight loss drugs are being compounded and having ingredients sourced from non-FDA approved sites
When NNMT activity is elevated as documented in obese adipose tissue, several cancer types, and aged skeletal muscle intracellular NAD+ availability decreases, SAM availability decreases, and downstream sirtuin activity (particularly SIRT1 and SIRT3) is reduced
Clinical studies have shown that tirzepatide can lead to significant weight loss in adults with obesity or overweight, even in people without diabetes
Approximately 25% to 40% of people with T2D use insulin as part of their therapy to control their disease